Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Delta-9-tetrahydrocannabinol and cannabidiol from extracts of the Cannabis sativa L. plant

EU orphan designation number: EU/3/16/1621   
Active ingredient: Delta-9-tetrahydrocannabinol and cannabidiol from extracts of the Cannabis sativa L. plant
Indication: Treatment of glioma
Sponsor: GW Pharma (International) B.V
Databankweg 26, Amersfoort, Utrecht, 3821 AL, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2016 Orphan designation EMA/OD/222/15 (2016)1115 of 17/02/2016
12/04/2019 Transfer of orphan designation EMA/OD/0000004763 (2019)2924 of 10/04/2019